Overview
Develop medical diagnostic technology to support the planning and execution of the treatment of cardiac arrhythmogenic areas by an ablation procedures. Based on the standard 12 lead ECG the device will localize the patient specific anatomical region from which ventricular tachycardia (VT) or premature ventricular contractions (PVC) originate. In a clinical feasibility study the accuracy of the technology will be tested and demonstrated.
